Wilex secures EUR9.93m from cap increase.
M2 PHARMA-February 1, 2012-Wilex secures EUR9.93m from cap increase(C)2012 M2 COMMUNICATIONS
1 February 2012 - German biopharmaceutical company Wilex AG (ETR:WL6) said on Wednesday it had secured gross proceeds of EUR9.93m (USD13.1m) from the implementation of a capital hike.
The company will use the finding to finance ongoing clinical trials as well as to strengthen its capital base.
Wilex issued a total of 3.2m new shares at a subscription price of EUR3.10 apiece and a subscription ratio of 27:4.
The company has thus raised its share capital to EUR24.8m from the prior EUR21.6m.
(EUR1 = USD1.317)
((Comments on this story may be sent to email@example.com))